The association between patent foramen ovale and unexplained syncope in pediatric patients

Runmei Zou1, Shuo Wang2, Ping Liu1

  • 1Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, No.139 Renmin Middle Road, Changsha, Hunan, 410011, China.

PubMed

Insights

Patent foramen ovale (PFO) may not increase syncope risk in children. This study found no significant association between PFO and syncope in pediatric patients, suggesting further research is needed.

Area of Science:

  • Cardiology
  • Pediatric Neurology
  • Clinical Medicine

Background:

  • Patent foramen ovale (PFO) is linked to stroke and syncope in adults.
  • PFO closure reduces recurrent cerebral events and syncope in adults.
  • The association between PFO and syncope in pediatric patients remains uninvestigated.

Purpose of the Study:

  • To investigate the association between patent foramen ovale (PFO) and unexplained syncope in pediatric patients.
  • To determine if PFO increases the risk of syncope in children.

Main Methods:

  • Retrospective analysis of 1001 pediatric patients (4-17 years) hospitalized for unexplained syncope, headache, dizziness, chest pain, or palpitation.
  • Exclusion of children with known causes of syncope or other systemic diseases.
  • Transthoracic echocardiography and contrast echocardiography to detect PFO and right-to-left shunting.

Main Results:

  • No significant difference in PFO incidence across syncope, headache/dizziness, chest pain, and palpitation groups (4.71%–6.17%).
  • Multivariate logistic regression indicated PFO is not associated with an increased risk of syncope (P=0.081).

Conclusions:

  • Patent foramen ovale (PFO) may not be a significant risk factor for syncope in pediatric patients.
  • Further large-scale, multicenter studies are warranted to confirm the association between PFO and unexplained pediatric syncope.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...